Consolidated standards of reporting trials (CONSORT) for traditional Chinese medicine: Current situation and future development

Frontiers of Medicine in China

Volumn 5, Issue 2, 2011, Pages 171-177

  Bian, Zhaoxiang ^a   Liu, Baoyan ^b   Moher, David ^c   Wu, Taixiang ^d   Li, Youping ^d   Shang, Hongcai ^e   Cheng, Chungwah ^a  

^a HONG KONG BAPTIST UNIVERSITY   (Hong Kong)

^b INSTITUTE OF CHINESE MATERIA MEDICA   (China)

^c CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

^d SICHUAN UNIVERSITY   (China)

^e TIANJIN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

CONSORT for TCM; Future development; Reporting standards

Indexed keywords

EID: 80355129340     PISSN: 16737342     EISSN: 16737458     Source Type: Journal    
DOI: 10.1007/s11684-011-0132-z     Document Type: Review

References (19)

1. Altman DG, Schulz KF, Moher D, Egger M, Davidoff F, Elbourne D, Gøtzsche PC, Lang T, CONSORT Group. The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med 2001; 134(8): 663-694
2. Schulz KF, Chalmers I, Grimes DA, Altman DG. Assessing the quality of randomization from reports of controlled trials published in obstetrics and gynecology journals. JAMA 1994; 272(2): 125-128
3. Moher D, Schulz KF, Altman DG. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. Lancet 2001; 357(9263): 1191-1194
4. Begg C, Cho M, Eastwood S, Horton R, Moher D, Olkin I, Pitkin R, Rennie D, Schulz KF, Simel D, Stroup DF. Improving the quality of reporting of randomized controlled trials. The CONSORT statement. JAMA 1996; 276(8): 637-639
5. Schulz KF, Altman DG, Moher D, CONSORT Group. CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. Ann Intern Med 2010; 152(11): 726-732
6. Cals JW, van Amelsvoort LG, Kotz D, Spigt MG. CONSORT 2010 Statement-unfinished update? J Clin Epidemiol 2011 Jan 3; DOI:10.1016/j.jclinepi.2010.10.007
7. Moher D, Jones A, Lepage L. Use of the CONSORT statement and quality of reports of randomized trials: a comparative before-andafter evaluation. JAMA 2001; 285(15): 1992-1995
8. CONSORT Group. Extensions of the CONSORT Statement. http://www.consort-statement.org
9. Bian ZX, Li YP, Moher D, Dagenais S, Liu L, Wu TX, Miao JX, Kwan AK, Song L. Improving the quality of randomized controlled trials in Chinese herbal medicine, part I: clinical trial design and methodology. J Chin Integr Med (Zhong Xi Yi Jie He Xue Bao) 2006; 4(2): 120-129 (in Chinese)
10. Bian ZX, Moher D, Dagenais S, Li YP, Liu L, Wu TX, Miao JX. Improving the quality of randomized controlled trials in Chinese herbal medicine, part II: control group design. J Chin Integr Med (Zhong Xi Yi Jie He Xue Bao) 2006; 4(2): 130-136 (in Chinese)
11. Bian ZX, Moher D, Dagenais S, Li YP, Wu TX, Liu L, Miao JX, Song L, Zhang HM. Improving the quality of randomized controlled trials in Chinese herbal medicine, part IV: applying a revised CONSORT checklist to measure reporting quality. J Chin Integr Med (Zhong Xi Yi Jie He Xue Bao) 2006; 4(3): 233-242 (in Chinese)
12. Wu TX, Li YP, Bian ZX, Chen KJ, Shang BL, Shang HC, Moher D. Consolidated standards for reporting trials of traditional Chinese medicine (CONSORT for TCM). Chin J Evid Based Med (Zhong Guo Xun Zheng Yi Xue Za Zhi) 2007; 7(8): 601-605 (in Chinese)
13. Wu TX, Li YP, Bian ZX, Chen KJ, Shang BL, Shang HC, Moher D. Consolidated standards for reporting trials of traditional Chinese medicine (CONSORT for TCM). Chin J Evid Based Med (Zhong Guo Xun Zheng Yi Xue Za Zhi) 2007; 7(8): 625-630
14. MacPherson H, White A, Cummings M, Jobst K, Rose K, Niemtzow R. Standards for reporting interventions in controlled trials of acupuncture: the STRICTA recommendations. Complement Ther Med 2001; 9(4): 246-249
15. MacPherson H, Altman DG, Hammerschlag R, Li YD, Wu TX, White A, Moher D. Revised standards for reporting interventions in clinical trials of acupuncture (STRICTA): extending the CONSORT statement. PLoS Med 2010; 7(6): e1000261
16. Cheng CW, Bian ZX, Li YP, Moher D, Wu TX, Dagenais S, Li J, Li TQ. How to explain the methodological rationale of randomized controlled trial on traditional Chinese medicine. Chin J Evid Based Med (Zhongguo Xun Zheng Yi Xue Za Zhi) 2008; (3): 152-154 (in Chinese)
17. Bian ZX, Moher D, Li YP, Wu TX, Dagenais S, Cheng CW, Li J, Li TQ. Precise reporting of traditional Chinese medicine interventions in randomized controlled trials. J Chin Integr Med (Zhong Xi Yi Jie He Xue Bao) 2008; 6(7): 661-667 (in Chinese)
18. Bian ZX, Moher D, Li YP, Wu TX, Dagenais S, Cheng CW, Li J, Li TQ. Appropriately selecting and concisely reporting the outcome measures of randomized controlled trials of traditional Chinese medicine. J Chin Integr Med (Zhong Xi Yi Jie He Xue Bao) 2008; 6(8): 771-775 (in Chinese)
19. Cheng CW, Bian ZX, Li YP, Moher D, Wu TX, Dagenais S, Li J, Li TQ. Transparently reporting adverse effects of traditional Chinese medicine interventions in randomized controlled trials. J Chin Integr Med (Zhong Xi Yi Jie He Xue Bao) 2008; 6(9): 881-886 (in Chinese)